Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Rapport | 2023
l'approvisionnement plus sécuritaire, la politique / le cadre de réglementation, les obstacles et les facilitateurs
Report | 2023
Safer supply, Policy/Regulatory, Barriers and enablers
This study aims to characterize the lay views and experiences with illicitly manufactured fentanyl (IMF)-contaminated methamphetamine (IMF/meth) and identify participants with unknown IMF exposures
Original research | 2023
Stimulants, Overdose, About PWUD, Illegal drugs
This study aims to measure the prevalence, frequency, timing, and rate of touchpoints that occurred prior to a fatal overdose where communities might intervene.
Original research | 2023
Overdose, About PWUD, Legal system/law enforcement, Hospitals, Mortality
Our objective was to examine the cost-effectiveness of flexible take-home buprenorphine-naloxone (BNX) versus methadone alongside the OPTIMA trial in Canada.
Original research | 2023
Substitution/OAT, Outcomes
We sought to better understand the experience of being part of a Safer Supply program from the perspective of current participants.
Original research | 2023
Safer supply, Evidence base, Policy/Regulatory, About PWUD, Diversion
Rural areas in the United States (US) are ravaged by the opioid overdose epidemic. Oconee County, an entirely rural county in northwest South Carolina, is likewise severely affected.
Original research | 2023
Rural/remote, Harm reduction
Infographic | 2023
Safer supply, Evidence base, Outcomes
Report | 2023
Safer supply, Evidence base, Outcomes
What is the association between school-level stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and prescription stimulant nonmedical use?
Original research | 2023
Youth, Stimulants, Diversion
Case study | 2023
Overdose, About PWUD, Wrap-around services, Digital health
Stereotypes portraying people who use criminalized drugs as incapable caregivers persist.
Original research | 2023
Sex/Gender , Harm reduction, About PWUD
Amidst an increasingly toxic drug supply, the pandemic disrupted essential substance use treatment and harm reduction services that reduce overdose risk for people who use drugs.
Original research | 2023
About PWUD, Substitution/OAT, Barriers and enablers, Equity
Health care providers navigated multiple layers of constraint during HAT implementation and delivery.
Original research | 2023
Safer supply, Barriers and enablers, About prescribers, About PWUD
We conducted a policy scan of UDS guidelines, examining the published clinical practice guidelines for each Canadian province and extracting all relevant data in March 2017.
Guidelines | 2018
Clinical guidance, Substitution/OAT, About prescribers
Policy | 2023
SCS/OPS, Policy/Regulatory, Social benefits
Urine toxicology testing (UTT) is often performed at the time of labor and delivery for pregnant patients to evaluate substance use.
Original research | 2023
Equity, Sex/Gender , Hospitals, Parents/caregivers
Low-barrier programs like mobile care units and street outreach programs have yielded increased access to buprenorphine and social services, however, OUD pertinent co-occurring behavioral health an
Original research | 2023
Wrap-around services, Substitution/OAT
The current study aimed to assess the feasibility of a modified same-day test-and-treat model in improving hepatitis C virus (HCV) care for people who inject drugs (PWID) living in resource-constra
Original research | 2023
About PWUD, Rural/remote, Wrap-around services
To date, little is known about what factors may contribute to the continuation of drug use during imprisonment.
Original research | 2023
About PWUD, Illegal drugs, Legal system/law enforcement
